Finding heart amyloidosis in bone scans
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks back at bone scans that were done for other reasons to see if they can spot a condition called cardiac amyloidosis, where abnormal protein builds up in the heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a bone scan (scintigraphy) using a specific radioactive tracer (99mTc-HMDP/DPD/PYP) for any reason.
- Your bone scan showed unexpected tracer activity in your heart, graded as Perugini grade 2 or higher, confirmed by a specialist.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a type of heart condition called transthyretin cardiac amyloidosis changes over time, using a special imaging test called a bone scan. The goal is to see if the scan can help track the disease and potentially improve care.
This study tests a faster type of bone imaging scan to help diagnose a rare heart condition where an abnormal protein builds up in the heart muscle. Researchers want to see if this newer imaging method works better than standard scans for detecting this condition.
This trial is testing older adults with heart failure to see if a heart condition called cardiac amyloidosis (a buildup of abnormal protein in the heart) is present. If you are 80 or older, have been in the hospital for heart failure in the past year, and have a thickened heart wall, you may be able to join.
This study collects information from adults who have been diagnosed with, or are being checked for, ATTR amyloidosis (a condition where abnormal protein builds up in the body) using a heart PYP scan. Your participation may help doctors better understand how these scans relate to diagnosis and follow-up over time.
This study uses a special PET scan tracer to see how consistent the images are in people with heart amyloidosis (a buildup of abnormal protein in the heart) and in people without the condition. The goal is to improve diagnosis and monitoring.
This study uses a hybrid PET/MRI scanner to take detailed images of the heart in people with amyloidosis. The goal is to see how well this scan shows the buildup of amyloid protein, which could help doctors better diagnose and manage the condition.
Hear when a new Cardiac Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.